Strengthening lifeskills among sexual minority adolescent men in the United States.
Linking YMSM to high quality, culturally competent HIV/STI testing and screening sites.
A Phase 1 open label study of a one-dose tenofovir (TFV) medicated douche.
A Phase 1 open label study of a single dose Elvitegravir insert at two dose levels administered rectally.
Evaluation of treatment as prevention messaging among HIV-affected communities.
Teaching and modeling inclusive sex education for parents of gay, bisexual, and queer adolescents.
Identifying parents' insight about best way to talk about sexual health with gay, bisexual, or queer sons.
Understanding fertility decisions among coupled sexual minority women as they try to conceive.
Youth perspectives to inform the next generation of HIV biomedical HIV prevention.
Implementation barriers & opportunities to optimize HIV testing and PrEP delivery among YMSM.
Sexual Health Inclusitivity during Family Talks for Lesbian, Bisexual, and Queer Girls
Reducing HIV risk among young men seeking partners online.
Addressing racial, sexual, and HIV stigma in black men's lives.
Exploring the smoking correlates of young sexual minority women.
Examining how structural factors contextualize HIV risk in Metro Detroit.
Understanding the online dating and relationship needs of young sexual minority men.
Using innovative mobile messaging for HIV prevention and care.
A randomized, double blind Phase 1 clinical trial of a dapivirine gel administered rectally.
A Phase 1 study of MK-2048/ Vicriviroc (MK-4176)/ MK 2048A intravaginal rings.
An open label, randomized Phase 1 study of dapivirine gel administered rectally. MTN
A randomized, open label cross-over study of three rectal microbicide placebo formulations.
A Phase 1 sequential volume escalation trial of PC-1005 administered rectally.
Assessing the role that community and network factors have on YMSM's PrEP behaviors.